Adenovirus-Mediated Thymidine Kinase Gene Therapy in Combination with Topotecan for Patients with Recurrent Ovarian Cancer: 2.5-Year Follow-Up

By Hasenburg A.   Tong X.-W.   Fischer P.D.   Rojas-Martinez A.   Nyberg-Hoffman C.   Kaplan A.L.   Kaufman R.H.   Ramzy I.   Aguilar-Cordova E.   Kieback D.G.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 549-554

Elsevier

Access to resources Recommend Favorite

Combination of adenovirus-mediated thymidine kinase gene therapy with cytotoxic chemotherapy in bladder cancer in vitro

By Freund C.T.F.   Tong X.-W.   Rowley D.   Engehausen D.   Frolov A.   Kieback D.G.   Lerner S.P.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 3, 2003-05 ,pp. : 197-205

Elsevier

Access to resources Recommend Favorite

Thymidine kinase/ganciclovir and cytosine deaminase/5-fluorocytosine suicide gene therapy-induced cell apoptosis in breast cancer cells

By Kong H.   Tao L.   Qi K.   Wang Y.   Li Q.   Du J.   Huang Z.  

Oncology Reports, Vol. 30, Iss. 3, 2013-09 ,pp. : 1209-1214

Spandidos Publications

Access to resources Recommend Favorite

In VivoStudies of Adenovirus-Based p53 Gene Therapy for Ovarian Cancer

By von Gruenigen V.E.   Santoso J.T.   Coleman R.L.   Muller C.Y.   Miller D.S.   Mathis J.M.  

Gynecologic Oncology, Vol. 69, Iss. 3, 1998-06 ,pp. : 197-204

Elsevier

Access to resources Recommend Favorite

High-Efficacy Thymidine Kinase Gene Transfer to Ovarian Cancer Cell Lines Mediated by Herpes Simplex Virus Type 1 Vector

By Wang M.   Rancourt C.   Navarro J.G.   Krisky D.   Marconi P.   Oligino T.   Alvarez R.D.   Siegal G.P.   Glorioso J.C.   Curiel D.T.  

Gynecologic Oncology, Vol. 71, Iss. 2, 1998-11 ,pp. : 278-287

Elsevier

Access to resources Recommend Favorite